S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7228 −0.33%
CLOSED · 20:30 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today302 insider buys this week · $300.6MCIRO short report next: Sep 15The week ahead
VR
INSIDER · CORT · CORCEPT THERAPEUTICS INC · PRESIDENT, ONCOLOGY

Vieira Roberto Wandenkolk

Every open-market transaction filed under this name, Sep 2 to Sep 2.

Filings
7
0 buys · 7 sells
Bought
open market, at cost
Sold
$6.5M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell1,225$115.44$141K−3.3%
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell5,621$114.58$644K−2.6%
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell1,606$113.72$183K−1.8%
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell974$112.40$109K−0.7%
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell1,537$111.37$171K+0.2%
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell23,770$110.70$2.6M+0.8%
Sep 2CORTCORCEPT THERAPEUTICS INCPresident, OncologySell23,600$109.35$2.6M+2.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.